scholarly journals Central Retinal Vein Occlusion Secondary to Ocular Trauma in a Young Patient

2021 ◽  
Vol 83 (1) ◽  
pp. 39-45
Author(s):  
Ailia Ahmed
Keyword(s):  
Central Retinal Vein Occlusion ◽  
Peripheral Vision ◽  
Ocular Trauma ◽  
Young Patients ◽  
Chief Complaint ◽  
Vein Occlusion ◽  
Asian Male ◽  
Blunt Ocular Trauma ◽  
Central Retinal Vein ◽  
Retinal Vein Occlusions

Central retinal vein occlusions (CRVO) occurring in young patients or due to a traumatic etiology is uncommon. This paper outlines the case of a 33-year-old Asian male who presented with a chief complaint of blurry peripheral vision and photophobia in his left eye, one week after sustaining blunt ocular trauma. He was diagnosed with a traumatic CRVO based on history and exam findings.

scholarly journals Nonischemic Central Retinal Vein Occlusion in an Adolescent Patient with Ulcerative Colitis

2011 ◽  
Vol 2011 ◽  
pp. 1-2 ◽  
Author(s):  
Deepak Vayalambrone ◽  
Tsveta Ivanova ◽  
Aseema Misra
Keyword(s):  
Retinal Vein Occlusion ◽  
Central Retinal Vein Occlusion ◽  
Pediatric Population ◽  
Extraintestinal Manifestations ◽  
Adolescent Patient ◽  
Vascular Thrombosis ◽  
Vein Occlusion ◽  
Inflammatory Bowel ◽  
Central Retinal Vein ◽  
Retinal Vein Occlusions

Inflammatory bowel disease (IBD) can present with extraintestinal manifestations occasionally involving the eye. Retinal vein occlusions are rarely seen and have never been reported in the pediatric population though vascular thrombosis can be associated with IBD. Here, we present a case of what we believe is the youngest reported patient with nonischemic central retinal vein occlusion (CRVO).

scholarly journals Anti-VEGF in a Marathon Runner’s Retinopathy Case

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Alexander Kahjun Soon ◽  
Paulo Ricardo Chaves de Oliveira ◽  
David Robert Chow
Keyword(s):  
Visual Acuity ◽  
Macular Edema ◽  
Central Retinal Vein Occlusion ◽  
Young Patients ◽  
Subretinal Fluid ◽  
Young Male ◽  
Intense Exercise ◽  
Effective Treatment Option ◽  
Vein Occlusion ◽  
Central Retinal Vein

Central retinal vein occlusion (CRVO) is one of the most common retinal vascular disorders. Intense exercise associated CRVO have been described in otherwise healthy young patients. We describe a case of a young male ultramarathoner who presented with a CRVO, presumably associated with dehydration, making part of a marathon runner’s retinopathy. Resolution of macular edema and subretinal fluid, with visual acuity improvement, was observed after 3 monthly injections of ranibizumab. Our case suggests that dehydration could be involved in the mechanism of CRVO in healthy young patients and ranibizumab may be an effective treatment option for marathon runner’s retinopathy.

CENTRAL RETINAL VEIN OCCLUSION IN YOUNG PATIENTS

Retina ◽  
2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Kyu Sang Eah ◽  
You Na Kim ◽  
Yu Jeong Park ◽  
Joo Yong Lee ◽  
June-Gone Kim ◽  
...  
Keyword(s):  
Retinal Vein Occlusion ◽  
Central Retinal Vein Occlusion ◽  
Young Patients ◽  
Vein Occlusion ◽  
Central Retinal Vein

Hypercoagulability and High Lipoprotein(a) Levels in Patients with Central Retinal Vein Occlusion

1994 ◽  
Vol 72 (01) ◽  
pp. 039-043 ◽  
Author(s):  
Francesco Bandello ◽  
Silvana Vigano’ D’Angelo ◽  
Mariella Parlavecchia ◽  
Alessandra Tavola ◽  
Patrizia Della Valle ◽  
...  
Keyword(s):  
Retinal Vein Occlusion ◽  
Central Retinal Vein Occlusion ◽  
Specific Treatment ◽  
Fibrin Deposition ◽  
Heparin Cofactor Ii ◽  
Lipoprotein A ◽  
Vein Occlusion ◽  
Acute Event ◽  
D Dimer ◽  
Central Retinal Vein

SummaryA series of coagulation parameters and lipoprotein(a) (Lp(a)) were explored in plasma from 40 patients with central retinal vein occlusion (CRVO, non-ischemic type n = 12; ischemic type n = 28) free of local and systemic predisposing factors, 1 to 12 months after the acute event. Forty age- and sex-matched patients with cataract served as controls. Prothrombin fragment 1.2 (FI.2), D-dimer, FVII:C - but not FVII: Ag - were higher and fibrinogen was lower in CRVO patients than in controls. Patients with non-ischemic CRVO had higher FI .2 and FVII:C and lower heparin cofactor II than patients with ischemic CRVO. Lp(a) levels greater than 300 mg/1 were observed in 12 patients with CRVO and in 4 controls (30% vs 10%, p <0.025). Patients with high Lp(a) - consistently associated with the S2 phenotype - had higher FVII:C, FVII:C/Ag ratio, and fibrinogen than the remaining CRVO patients. Plasma FI.2 and D-dimer correlated fairly in controls (r = 0.41) and patients with normal Lp(a) levels (r = 0.55), but they did not in the group of patients with high Lp(a) (r = 0.19), where the latter parameter was negatively related to D-dimer (r = −0.55). There was no dependence of the abnormalities observed on the time elapsed from vein occlusion. The findings of activated FVII and high FI.2, D-dimer, and Lp(a) are not uncommon in patients with CRVO. Increased thrombin formation with fibrin deposition and impaired fibrinolysis may play a role in the pathophysiology of CRVO and require specific treatment

Sign in / Sign up

Export Citation Format

Share Document